{"nct_id":"NCT03055195","title":"Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis","status":"TERMINATED","status_verified_date":"2020-02","start_date":"2017-03-21","start_date_type":"ACTUAL","primary_completion_date":"2017-12-06","primary_completion_date_type":"ACTUAL","completion_date":"2017-12-06","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}